What We Do

Using our HEALER™ technology, we develop innovative prescription drug products based on small molecule derivatives of n-3 fatty acids to address new indications with significant unmet medical needs in gastrointestinal and cardiometabolic diseases.


TP-252 for familial adenomatous polyposis

TP-4311 for post operative ileus

TP-113 for type 2 diabetes

TP-452 for dyslipidemia

Learn more about our pipeline. »»